Literature DB >> 11376110

Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes.

K S Bramlett1, Y Wu, T P Burris.   

Abstract

Nuclear receptors (NRs) require coactivators to efficiently activate transcription of their target genes. Many coactivators including the p160 proteins utilize a short NR box motif to recognize the ligand-binding domain of the NR when it is activated by ligand. To investigate the ability of various ligands to specify the affinity of NR boxes for a ligand-bound NR, we compared the capacity of p160 NR boxes to be recruited to estrogen receptor (ERalpha) and ERbeta in the presence of 17beta-estradiol, diethylstilbestrol, and genestein. A time-resolved fluorescence-based binding assay was used to determine the dissociation constants for the 10 NR boxes derived from the three p160 coactivators for both ER subtypes in the presence of the each of the agonists. While the affinity of some NR boxes for ER was independent of the agonist, we identified several NR boxes that had significantly different affinities for ER depending on which agonist was bound to the receptor. Therefore, an agonist may specify the affinity of an NR for various NR boxes and thus regulate the coactivator selectivity of the receptor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11376110     DOI: 10.1210/mend.15.6.0649

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  21 in total

1.  Hormone binding and co-regulator binding to the glucocorticoid receptor are allosterically coupled.

Authors:  Samuel J Pfaff; Robert J Fletterick
Journal:  J Biol Chem       Date:  2010-03-24       Impact factor: 5.157

2.  Quantification of ligand-regulated nuclear receptor corepressor and coactivator binding, key interactions determining ligand potency and efficacy for the thyroid hormone receptor.

Authors:  M Jeyakumar; Paul Webb; John D Baxter; Thomas S Scanlan; John A Katzenellenbogen
Journal:  Biochemistry       Date:  2008-06-18       Impact factor: 3.162

3.  Exploration of dimensions of estrogen potency: parsing ligand binding and coactivator binding affinities.

Authors:  M Jeyakumar; Kathryn E Carlson; Jillian R Gunther; John A Katzenellenbogen
Journal:  J Biol Chem       Date:  2011-02-14       Impact factor: 5.157

Review 4.  Development of subtype-selective oestrogen receptor-based therapeutics.

Authors:  Stefan Nilsson; Konrad F Koehler; Jan-Åke Gustafsson
Journal:  Nat Rev Drug Discov       Date:  2011-09-16       Impact factor: 84.694

5.  Fluorescence anisotropy microplate assay to investigate the interaction of full-length steroid receptor coactivator-1a with steroid receptors.

Authors:  Chen Zhang; Steven K Nordeen; David J Shapiro
Journal:  Methods Mol Biol       Date:  2013

6.  Nutritional flavonoids impact on nuclear and extranuclear estrogen receptor activities.

Authors:  Paola Galluzzo; Maria Marino
Journal:  Genes Nutr       Date:  2006-09       Impact factor: 5.523

Review 7.  Potential of selective estrogen receptor modulators as treatments and preventives of breast cancer.

Authors:  Jing Peng; Surojeet Sengupta; V Craig Jordan
Journal:  Anticancer Agents Med Chem       Date:  2009-06       Impact factor: 2.505

8.  Quantification of the vitamin D receptor-coregulator interaction.

Authors:  Arnaud Teichert; Leggy A Arnold; Steve Otieno; Yuko Oda; Indre Augustinaite; Tim R Geistlinger; Richard W Kriwacki; R Kiplin Guy; Daniel D Bikle
Journal:  Biochemistry       Date:  2009-02-24       Impact factor: 3.162

Review 9.  Minireview: Not picking pockets: nuclear receptor alternate-site modulators (NRAMs).

Authors:  Terry W Moore; Christopher G Mayne; John A Katzenellenbogen
Journal:  Mol Endocrinol       Date:  2009-11-20

10.  Structure, affinity, and availability of estrogen receptor complexes in the cellular environment.

Authors:  Eric M Kofoed; Martin Guerbadot; Fred Schaufele
Journal:  J Biol Chem       Date:  2009-11-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.